August 8, 2026
Sourcing a sterile IV antibiotic is a different exercise from buying tablets off a rate list. When you need a reliable linezolid injection manufacturer, the questions that matter are about cleanrooms, vial integrity, batch consistency and whether the maker can hold supply steady for a hospital tender or a growing distribution territory. This page is for distributors, institutional buyers and franchise partners who want to understand how linezolid IV is actually sourced in India — the available pack formats, what sterile production demands, and how third-party and PCD supply arrangements work in practice.
Linezolid for intravenous use is supplied as a ready-to-infuse solution, which means there is no reconstitution at the point of care. The format most distributors and hospital pharmacies stock is a single-use infusion bag or bottle, and the common commercial presentation in India is a 200mg/100ml IV pack. Knowing the exact presentation up front matters because it drives cold-chain handling, carton dimensions, shelf-life claims and how the product slots into a hospital formulary or a wholesaler’s cold list.
| Attribute | Typical for linezolid IV |
|---|---|
| Form | Ready-to-use IV infusion (no reconstitution) |
| Common pack | 200mg / 100ml infusion bag or bottle |
| Brand (Biozia) | ZIALID-IV |
| Drug class | Oxazolidinone antibiotic (prescription / Schedule) |
| Channel | Hospitals, critical-care units, institutional tenders, distributors |
This is commercial sourcing information only. Pack details and specifications should be confirmed in writing for your order; this page does not provide dosing or clinical guidance.
An IV infusion goes straight into the bloodstream, so the bar for how it is made is far higher than for an oral product. Linezolid injection has to be filled in a controlled aseptic environment: classified cleanrooms, validated filling lines, container-closure integrity testing and a sterility assurance programme behind every batch. This is exactly the capability gap that catches buyers out. A maker who can press tablets cheaply may have no sterile line at all. When you shortlist a linezolid injection manufacturer, treat proven aseptic capability as the first filter, not a detail to check later.
Biozia’s strength sits in precisely this category — injectables and IV infusions are core to its range alongside ophthalmic and oral forms, so sterile production is a standing capability rather than an occasional job.
How you buy linezolid IV depends on whether you want it under your own brand or want territory rights to sell an existing one. Both routes avoid the cost of building a sterile plant of your own.
You provide the brand name, artwork and required specs; the manufacturer produces linezolid IV to that brief on its certified sterile line and ships finished, labelled stock to you. This suits marketing companies and distributors who want their own label across an antibiotic range.
You take distribution and promotional rights for ZIALID-IV (and other Biozia products) in a defined territory, often on a monopoly basis. This is the lower-entry route for individuals and small firms who want an established brand and ready packaging without managing artwork or specs themselves.
Institutional and trade buyers of a sterile antibiotic run a tighter diligence list than they would for general products. The usual priorities:
Minimum order quantities for a sterile infusion are set per batch rather than per unit, so the economics improve with larger runs. Packaging — the infusion container, carton and any inserts — is fixed against your brand for third-party orders or supplied as standard ZIALID-IV trade packs for franchise partners. To get accurate terms, share your intended quantity, pack format and whether you want your own label or franchise rights; a written quote then follows with net rate, MOQ and dispatch timeline.
| What to share when you enquire | Why it matters |
|---|---|
| Quantity / batch volume | Sets the per-unit price and MOQ band |
| Supply route | Third-party label vs PCD franchise changes the packaging path |
| Territory | Needed to confirm monopoly availability for franchise |
| Brand & artwork | Required for own-label third-party production |
| Documents | Drug License and GST are the entry tickets to supply |
Indicative PCD franchise entry runs roughly ₹25,000 to ₹1,00,000 for a single territory, with margins commonly in the 20% to 40%+ range. Treat these as indicative and confirm exact terms.
Biozia Lifesciences manufactures linezolid IV as ZIALID-IV from a WHO-GMP and ISO-certified facility in Yamunanagar, Haryana, with genuine strength in sterile injectables, IV infusions and ophthalmic forms across a 250+ formulation range and 9 dosage forms. Its leadership carries 40+ years in pharmaceuticals, and supply runs pan-India for both third-party and PCD franchise partners.
Need linezolid IV under your label or a franchise territory? Request a manufacturing quote from Biozia Lifesciences →
Biozia manufactures linezolid IV as a ready-to-use infusion under the brand ZIALID-IV, with the 200mg/100ml format being the common commercial presentation. Exact pack and specification details are confirmed in writing against your order.
Yes. Through third-party manufacturing you supply the brand name, artwork and required specs, and Biozia produces it on its certified sterile line and ships finished, labelled stock to you.
Yes. ZIALID-IV can be offered to PCD franchise partners with monopoly rights in a defined territory, subject to availability. You would distribute and promote the existing brand rather than manage your own label.
A Drug License and GST registration are the essentials for any pharmaceutical supply arrangement, along with brand or trademark details if you are going the own-label third-party route.
An IV product is administered directly into the bloodstream, so it must be made under validated aseptic conditions with full sterility assurance. A WHO-GMP-certified sterile line is the baseline that serious distributors and hospital buyers expect.
Author: Biozia Lifesciences Editorial Team — insights drawn from Biozia Lifesciences’ WHO-GMP & ISO-certified manufacturing and PCD franchise operations in India, led by 40+ years of industry experience. This article is general business information and not medical or legal advice.
Get monopoly rights, a wide product range and full marketing support in your territory.